Your browser doesn't support javascript.
loading
A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer.
Onaka, Takashi; Kato-Ogura, Aiko; Otsuka, Yasuyuki; Iwai, Fumie; Yonezawa, Akihito.
Affiliation
  • Onaka T; Department of Hematology, Kokura Memorial Hospital, 3-2-1,Asano Kokura-kita, Kitakyushu, Japan. takashionaka3@gmail.com.
  • Kato-Ogura A; Department of Hematology, Kokura Memorial Hospital, 3-2-1,Asano Kokura-kita, Kitakyushu, Japan.
  • Otsuka Y; Department of Hematology, Kokura Memorial Hospital, 3-2-1,Asano Kokura-kita, Kitakyushu, Japan.
  • Iwai F; Department of Hematology, Kokura Memorial Hospital, 3-2-1,Asano Kokura-kita, Kitakyushu, Japan.
  • Yonezawa A; Department of Hematology, Kokura Memorial Hospital, 3-2-1,Asano Kokura-kita, Kitakyushu, Japan.
Ann Hematol ; 101(2): 457-458, 2022 Feb.
Article in En | MEDLINE | ID: mdl-33846854

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Prostatic Neoplasms / Pyrazines / Leukemia, Myeloid, Acute / Bone Marrow Neoplasms / Aniline Compounds Limits: Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Prostatic Neoplasms / Pyrazines / Leukemia, Myeloid, Acute / Bone Marrow Neoplasms / Aniline Compounds Limits: Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Germany